4568:TYO
Daiichi Sankyo Co Ltd
2 709,00 ¥
arrow_downward
-1,15%(-31,50) 1 d.
2. okt., 15:30:00 GMT+9 · JPY
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: 4568…
Atvērt
2 720 ¥
Augsta
2 751 ¥
Zema
2 704 ¥
Tirgus kapitalizācija
5,05 trilj.
Vid. apjoms
6,01 milj.
Apjoms
5,14 milj.
Dividende
2,88%
Ceturkšņa dividendes
20 ¥
Cenas/peļņas attiecība
20,52
Augstākā 52 ned.
4 178 ¥
Zemākā 52 ned.
2 390 ¥
Peļņa uz vienu akciju
132 ¥
Apgrozībā esošās akcijas
647,77 milj.
Darbinieku skaits
20 tūkst.
Atvērt
2 720 ¥
Augsta
2 751 ¥
Zema
2 704 ¥
Tirgus kapitalizācija
5,05 trilj.
Vid. apjoms
6,01 milj.
Apjoms
5,14 milj.
Dividende
2,88%
Ceturkšņa dividendes
20 ¥
Cenas/peļņas attiecība
20,52
Augstākā 52 ned.
4 178 ¥
Zemākā 52 ned.
2 390 ¥
Peļņa uz vienu akciju
132 ¥
Apgrozībā esošās akcijas
647,77 milj.
Darbinieku skaits
20 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
Pharmaceutical Executive
·
pirms 12 stundām
Roundup: Novartis & Abogen Enter Licensing and Option Agreement, AstraZeneca and Daiichi Sankyo Enter Clinical Collaboration with Summit Therapeutics
Stocktwits
·
pirms 13 stundām
SMMT Stock Gets Another Catalyst: Summit, AstraZeneca, Daiichi Sankyo Expand Cancer Drug Push
Yahoo Finance
·
pirms 18 stundām
Daiichi Sankyo (TSE:4568) Faces Fresh Court Uncertainty After Appeal In Fortis Case
Reuters
·
pirms 19 stundām
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination
Profils
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
Par “Daiichi Sankyo Co Ltd”
ĢenerāldirektorsHiroyuki Okuzawa
Darbinieki20,2 tūkst.
Dibināšanas datums2005. gada 28. sept.
Galvenais birojsChuo City, Tokija, Japāna
Sektors-
Tīmekļa vietnedaiichisankyo.co.jp